Naozumi Ohnishi

Title: Naozumi Ohnishi: Innovator in Pharmaceutical Suspensions

Introduction

Naozumi Ohnishi is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of oral pharmaceutical suspensions. With a total of 2 patents to his name, Ohnishi continues to push the boundaries of innovation in medicine.

Latest Patents

Ohnishi's latest patents focus on a novel oral pharmaceutical suspension of Cefdinir crystal. The first patent describes a unique kit for the preparation of an oral pharmaceutical suspension containing crystal form C Cefdinir. This innovative approach aims to enhance the efficacy and usability of Cefdinir, a widely used antibiotic. The second patent reiterates the same invention, emphasizing its importance in providing a reliable and effective medication option.

Career Highlights

Naozumi Ohnishi is currently associated with Astellas Pharma GmbH, a leading global pharmaceutical company. His work at Astellas has allowed him to collaborate with other talented professionals in the industry, furthering the development of groundbreaking pharmaceutical solutions.

Collaborations

Ohnishi has worked alongside notable colleagues such as Satoshi Kitamura and Shuhei Deguchi. Their combined expertise has contributed to the successful advancement of their projects and innovations.

Conclusion

Naozumi Ohnishi stands out as a key figure in the pharmaceutical industry, with his innovative patents paving the way for improved medical treatments. His dedication to research and development continues to impact the field positively.